-

About FDA

  • Share Share this page

FDA Forms

If your PDF form is not working you may need to upgrade your software to a newer version of Adobe Reader.  Adobe Reader can be downloaded for Free at  http://get.adobe.com/reader/ 

Form Date Food and Drugs Administration Forms Format Contact Info
0356h  10/2005 {FDA has OMB approval to use the form until 6/30/2010} Application to Market a New Drug, Biologic or an Antibiotic Drug for Human Use  (PDF - 264KB) CBER MATT at 301-827-2000
CDER Drug Info at 301-796-3400
1571  04/2006 Investigational New Drug Application (IND) [Instructions]  (HTM - 0KB) CDER Drug Info
301-796-3400
1571  04/2006 {FDA has OMB approval to use the form until 8/31/2011}. Investigational New Drug Application  (PDF - 221KB) CBER MATT at 301-827-2000
CDER Drug Info at 301-796-3400
1572  05/2006 {FDA has OMB approval to use the form until 8/31/2011}. Statement of Investigator  (PDF - 208KB) CBER MATT at 301-827-2000
CDER Drug Info at 301-796-3400
2252  06/2008 Transmittal of Annual Report for Drugs and Biologics for Human Use  (PDF - 339KB) CBER MATT at 301-827-2000
CDER Drug Info at 301-796-3400
2253  06/2008 Transmittal of Advertisements and Promotional Labeling for Drugs and Biologics for Human Use  (PDF - 351KB) DDMAC
301-796-1200
2626  07/2004 New Drug Application/Biologic Licensing Application (Blue Folder) Archival  (HTML - 14KB) CBER MATT at 301-827-2000
CDER Drug Info at 301-796-3400
2626a  07/2004 New Drug Application/Biologic Licensing Application (Red Folder) Chemistry  (HTML - 14KB) CBER MATT at 301-827-2000
CDER Drug Info at 301-796-3400
2626b  07/2004 New Drug Application/Biologic Licensing Application (Yellow Folder) Pharmacology  (HTML - 14KB) CBER MATT at 301-827-2000
CDER Drug Info at 301-796-3400
2626c  07/2004 New Drug Application/Biologic Licensing Application (Orange Folder) Pharmacokinetic  (HTML - 14KB) CBER MATT at 301-827-2000
CDER Drug Info at 301-796-3400
2626d  07/2004 New Drug Application/Biologic Licensing Application (White Folder) Microbiology  (HTML - 14KB) CBER MATT at 301-827-2000
CDER Drug Info at 301-796-3400
2626e  07/2004 New Drug Application/Biologic Licensing Application (Tan Folder) Clinical Data  (HTML - 14KB) CBER MATT at 301-827-2000
CDER Drug Info at 301-796-3400
2626f  07/2004 New Drug Application/Biologic Licensing Application (Light Green Folder) Statistics  (HTML - 14KB) CBER MATT at 301-827-2000
CDER Drug Info at 301-796-3400
2626h  07/2004 New Drug Application/Biologic Licensing Application (Maroon Folder) Field Submission Chemistry  (HTML - 14KB) CBER MATT at 301-827-2000
CDER Drug Info at 301-796-3400
2657  06/2009 Drug Product Listing (HTML)  (HTM - 0KB) eDRLS@fda.hhs.gov
2658  06/2009 Registered Establishments Report of Private Label Distributors (HTML)  (HTM - 0KB) eDRLS@fda.hhs.gov
2675  08/1990 Investigational New Drug Folder (Red)  (HTML - 14KB) CDER Drug Info at 301-796-3400
2675a  10/1986 Investigational New Drug Folder (Green)  (HTML - 14KB) CDER Drug Info at 301-796-3400
2675b  10/1986 Investigational New Drug Folder (Orange)  (HTML - 14KB) CDER Drug Info at 301-796-3400
2914  08/2008 Radioactive Drug Research Committee (RDRC) Report on Research Use of Radioactive Drugs Membership Summary  (PDF - 429KB) RDRC
301-796-2050
2915  08/2008 Radioactive Drug Research Committee (RDRC) Report on Research Use of Radioactive Drugs Study Summary  (PDF - 856KB) RDRC
301-796-2050
3316  08/1985 DRUG MASTER FILE REVIEW BINDER-Red  (HTML - 14KB) CDER Drug Info at 301-796-3400
3316a  08/1985 DRUG MASTER FILE ARCHIVAL BINDER-Blue  (HTML - 14KB) CDER Drug Info at 301-796-3400
3331  01/2009 NDA Field Alert Report  (PDF - 425KB) Juliaette Johnson
301-827-8928
3397  01/2007 User Fee Cover Sheet  (HTM - 0KB) Mike Jones
301-443-5151
3437  06/1996 CDER Pediatric Use Supplement  (PDF - 36KB) CDR
301-827-4210
3454  04/2006 Certification: Financial Interest and Arrangements of Clinical Investigator  (PDF - 47KB) Leah W. Ripper
301-796-1282
3455  04/2006 Disclosure: Financial Interest and Arrangements of Clinical Investigators  (PDF - 56KB) Leah W. Ripper
301-796-1282
3542  12/2008 Patent Information Submitted Upon and After Approval of An NDA or Supplemen  (PDF - 420KB) Mary Ann Holovac, R.Ph.
240-276-8971
3542a  12/2008 Patent Information Submitted With the Filing of An NDA, Amendment, or Supp  (PDF - 417KB) Mary Ann Holovac
301-827-5846
3613b  06/2006 Supplementary Information Certificate of a Pharmaceutical Product  (PDF - 328KB) Import/Export Team
CBER 301-827-6201 or
CDER 301-827-8940 or
CDRH 301-796-7400 or
CVM 240-276-0132
3625  10/2008 DSI Complaint Record  (PDF - 378KB) Joseph Salewski
301-796-3395
3664  07/2007 My Medicine Record  (PDF - 331KB) Cindi Fitzpatrick
301-796-3115
3671  02/2009 Common EMEA/FDA Application for Orphan Medicinal Product Designation  (PDF - 554KB) Kathy Needleman
301-827-3666
3674  11/2008 Certification of Compliance, under 42 U.S.C. , 282(j)(5)(B), with Requireme  (PDF - 411KB) Jarilyn Dupont
301-796-4716
-
-
-
-
-
-